Liaison Treatment for Metastatic Spinal Tumors.
a SRE
liaison treatment
metastatic spinal tumor
multidisciplinary treatment
Journal
Spine surgery and related research
ISSN: 2432-261X
Titre abrégé: Spine Surg Relat Res
Pays: Japan
ID NLM: 101718059
Informations de publication
Date de publication:
2020
2020
Historique:
received:
12
11
2019
accepted:
20
01
2020
entrez:
1
9
2020
pubmed:
31
8
2020
medline:
31
8
2020
Statut:
epublish
Résumé
The cancer board system employed at many hospitals and treatment centers involves multidisciplinary healthcare teams, including physicians, and the timing of treatment generally follows that of a consultation model. Thus, it is difficult to detect spinal metastases using the current implementation of the cancer board system, which can lead to delays in treatment. A new multidisciplinary treatment strategy for patients with metastatic spinal tumors was designed, and 745 patients were treated based on this strategy. In the first 5 years using the liaison treatment approach, 745 patients were diagnosed with metastatic spinal tumor. Tumors were discovered before a skeletal-related event (SRE) in 704 patients and after an SRE in 41 patients. We conducted our analysis in two patient groups: those with and without an SRE at the time of treatment initiation. In most patients, the average spinal instability neoplastic score was 5.2, which indicates that we were able to detect the spinal tumor before a significant breakdown of the spinal support system. Ninety-five percent of patients were classified according to the Frankel grade classification during their initial diagnosis, and many patients initially underwent treatment before the onset of paralysis. Of patients with an SRE, 33% were Frankel grade E, indicating that approximately half were paralyzed at initial diagnosis. The median survival duration was prolonged by approximately 9 months in patients without an SRE compared with those with an SRE. Orthopedic spine surgeons are responsible for maintaining activities of daily living, improving quality of life, and prolonging life expectancy in patients with metastatic spinal tumors. The results of this study revealed that the liaison treatment system for metastatic spinal tumors has made it possible to successfully prevent SREs without neurological deficits and to prolong survival.
Identifiants
pubmed: 32864488
doi: 10.22603/ssrr.2019-0105
pmc: PMC7447348
doi:
Types de publication
Journal Article
Langues
eng
Pagination
223-228Informations de copyright
Copyright © 2020 by The Japanese Society for Spine Surgery and Related Research.
Déclaration de conflit d'intérêts
Conflicts of Interest: The authors declare that there are no relevant conflicts of interest.
Références
J Natl Cancer Inst. 2002 Oct 2;94(19):1458-68
pubmed: 12359855
Am J Clin Oncol. 1982 Dec;5(6):649-55
pubmed: 7165009
Spine (Phila Pa 1976). 2010 Oct 15;35(22):E1221-9
pubmed: 20562730
Cancer Med. 2014 Oct;3(5):1359-67
pubmed: 25044999
J Bone Joint Surg Br. 2005 May;87(5):698-703
pubmed: 15855375
J Natl Cancer Inst. 2001 Apr 4;93(7):534-8
pubmed: 11287447
Tumori. 2009 May-Jun;95(3):291-7
pubmed: 19688966
Oncology (Williston Park). 2003 Jun;17(6):845-57; discussion 862-3, 867
pubmed: 12846127
Prostate Cancer Prostatic Dis. 2016 Dec;19(4):380-384
pubmed: 27377207
JBJS Rev. 2018 May;6(5):e6
pubmed: 29762343
Harefuah. 1996 Dec 1;131(11):457-62, 536
pubmed: 9043151
Spine (Phila Pa 1976). 2001 Feb 1;26(3):298-306
pubmed: 11224867
Spine (Phila Pa 1976). 2005 Oct 1;30(19):2186-91
pubmed: 16205345
Cancers (Basel). 2018 May 24;10(6):
pubmed: 29795015
Cancer Control. 2012 Apr;19(2):122-8
pubmed: 22487974
Orthop Surg. 2017 May;9(2):145-151
pubmed: 28544780
Crit Rev Oncol Hematol. 1999 Jun;31(1):89-96
pubmed: 10532193
J Orthop Surg Res. 2018 Feb 5;13(1):30
pubmed: 29402333
Lancet Oncol. 2005 Jan;6(1):15-24
pubmed: 15629272